EUVIMEDEUVIMED entdecken
Crossref

Heterogeneity and Stratification of Preimplantation Genetic Grafting (PGT-A) Testing in Three Adapted Populations: A Future Study

刘慧 曹

Journal of Clinical Personalized Medicine · 2026 · 05 (04) · 28-37

DOI: 10.12677/jcpm.2026.54221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Personalized Medicine, 2026. Verfasst von 刘慧 曹. Die Arbeit nennt 50 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

背景:高龄(Advanced Maternal Age, AMA)、复发性流产(Recurrent Spontaneous Abortion, RSA)、反复种植失败(Recurrent Implantation Failure, RIF)是胚胎植入前非整倍体检测(Preimplantation Genetic Testing for Aneuploidy, PGT-A)的三大核心适应症。然而,目前针对这三类人群的研究多为独立的单一人群分析,研究设计、纳入标准、结局指标等关键因素存在显著差异,导致研究结论难以横向比较,临床决策缺乏统一证据支持。目的:系统梳理PGT-A在高龄、RSA、RIF三类人群中的研究现状,重点分析研究设计的异质性及其对结论可比性的影响,揭示当前研究的局限性与未来方向。方法:检索国内外相关文献,对三类人群的研究进行归纳,比较不同研究在纳入标准、对照组设置、混杂因素等方面的差异。结果:三类人群的研究在关键设计要素上存在显著异质性,导致不同人群、不同研究间的结论无法直接横向比较。目前尚缺乏将三类人群置于同一研究框架下进行分层比较的高质量研究。结论:开展基于多中心、大样本、规范的统一设计、对三大适应症进行分层比较的临床研究,对于PGT-A的真实临床价值、指导个体化治疗具有重要意义。 Background: Advanced maternal age (AMA), recurrent spontaneous abortion (RSA), and recurrent implantation failure (RIF) are the three core indications for preimplantation genetic testing for aneuploidy (PGT-A). However, current studies on these three populations are mostly independent single-population analyses, with significant differences in key factors such as study design, inclusion criteria, and outcome measures, making cross-sectional comparisons of research conclusions difficult and lacking unified evidence to support clinical decisions.

Objective

To systematically review the current research status of PGT-A in the three populations of advanced maternal age, RSA, and RIF, focusing on analyzing the heterogeneity of study design and its impact on the comparability of conclusions, revealing the limitations of current research and future directions.

Methods

Relevant domestic and international literature was retrieved, and studies on the three populations were summarized, comparing differences in inclusion cri, control group settings, and confounding factors among different studies.

Results

Significant heterogeneity exists in key design elements among the studies of the three populations, making direct cross-sectional comparisons of conclusions between different populations and different studies impossible. Currently, there is a lack of high-quality studies that stratify and compare the three population groups within the same research framework.

Conclusion

Conducting multi-center, large-sample, standardized, and uniformly designed clinical studies that stratify and compare the three indications is of great significance for understanding the true clinical value of PGT-A and guiding individualized treatment.

Zitieren

APA

曹, 刘. (2026). Heterogeneity and Stratification of Preimplantation Genetic Grafting (PGT-A) Testing in Three Adapted Populations: A Future Study. Journal of Clinical Personalized Medicine, 05(04), 28-37. https://doi.org/10.12677/jcpm.2026.54221

Vancouver

曹 刘. Heterogeneity and Stratification of Preimplantation Genetic Grafting (PGT-A) Testing in Three Adapted Populations: A Future Study. Journal of Clinical Personalized Medicine. 2026;05(04):28-37. doi:10.12677/jcpm.2026.54221

BibTeX
@article{2026,
  author = {曹, 刘慧},
  title = {Heterogeneity and Stratification of Preimplantation Genetic Grafting (PGT-A) Testing in Three Adapted Populations: A Future Study},
  journal = {Journal of Clinical Personalized Medicine},
  year = {2026},
  volume = {05},
  number = {04},
  pages = {28--37},
  doi = {10.12677/jcpm.2026.54221}
}
Kostenlos starten →